Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Int J Parasitol Drugs Drug Resist ; 24: 100529, 2024 Apr.
Article de Anglais | MEDLINE | ID: mdl-38461700

RÉSUMÉ

Earlier evidences showed that diglycosyl diselenides are active against the infective stage of African trypanosomes (top hits IC50 0.5 and 1.5 µM) but poorly selective (selectivity index <10). Here we extended the study to 33 new seleno-glycoconjugates with the aim to improve potency and selectivity. Three selenoglycosides and three glycosyl selenenylsulfides displayed IC50 against bloodstream Trypanosoma brucei in the sub-µM range (IC50 0.35-0.77 µM) and four of them showed an improved selectivity (selectivity index >38-folds vs. murine and human macrohages). For the glycosyl selenylsulfides, the anti-trypanosomal activity was not significantly influenced by the nature of the moiety attached to the sulfur atom. Except for a quinoline-, and to a minor extent a nitro-derivative, the most selective hits induced a rapid (within 60 min) and marked perturbation of the LMWT-redox homeostasis. The formation of selenenylsulfide glycoconjugates with free thiols has been identified as a potential mechanism involved in this process.


Sujet(s)
Trypanocides , Trypanosoma brucei brucei , Trypanosoma , Maladie du sommeil , Animaux , Souris , Humains , Homéostasie , Oxydoréduction , Maladie du sommeil/traitement médicamenteux , Trypanocides/pharmacologie , Trypanocides/usage thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE